Keywords: Melanma, Biomarker, Neuropilin-2, Boston University, Hohns Hopkins, Cancer research

Researchers discover possible biomarker and therapeutic target for melanoma

Article | 18 March 2011

Researchers at Boston University School of Medicine (BUSM) in the USA, in collaboration with Johns Hopkins University, have identified a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in